Sarah is interested in health, welfare, and labor law and policy, and how race and gender discrimination have shaped the American welfare state.
Sarah has worked as a health policy researcher at the University of Pennsylvania, an Iowa caucus organizer for Elizabeth Warren's presidential campaign, and an elections data scientist at BallotReady, a civic tech firm.
B.A., Economics and Political Science (with distinction). Yale College, 2018
DiMagno SSP, Glickman A, Emanuel EJ. Accelerated Approval of Cancer Drugs—Righting the Ship of the US Food and Drug Administration. JAMA Intern Med. Published online May 28, 2019. doi:10.1001/jamainternmed.2019.0584.
DiMagno SSP, Emanuel EJ. Pricing a Year of Progression-Free Survival: When Is the Cost of Cancer Drugs Unreasonable? JAMA Dermatol. 2019;155(1):15–16. doi:10.1001/jamadermatol.2018.3753.
Emanuel EJ, Zhang C, Glickman A, Gudbranson E, DiMagno SSP, Urwin JW. Drug Reimbursement Regulation in 6 Peer Countries. JAMA Intern Med. Published online September 28, 2020. doi:10.1001/jamainternmed.2020.4793
Glickman A, DiMagno SSP, Emanuel EJ. Next Phase in Effective Cost Control in Health Care. JAMA. Published online March 07, 2019. doi:10.1001/jama.2019.1608.
DiMagno, S., 2016. Strict Scrutiny & a New Class of Plaintiffs: Legal Strategies in King v. Smith. Columbia Undergraduate Law Review, 11(2), pp.1-18.